HCM - HUTCHMED China Limited Stock Trading

HUTCHMED (China) Limited(NASDAQ: HCM) stock trading description contact officers and directors.

About HUTCHMED (China) Limited

Not available

Stock Information

HUTCHMED (China) Limited Company Name:

HCM Stock Symbol:

NASDAQ Market:

Get HCM Alerts

News, Short Squeeze, Breakout and More Instantly...

HCM - Inmagene and HUTCHMED Announce First Participant in Global Phase I Trial of IMG-004

SAN DIEGO and SHANGHAI, China and HONG KONG, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Inmagene Biopharmaceuticals (" Inmagene ") and HUTCHMED (China) Limited (“ HUTCHMED ”) (Nasdaq/AIM:HCM; HKEX:13) announce today that the first participant, based in the Unite...
HCM - HUTCHMED and AstraZeneca Announce that TAGRISSO® Plus Savolitinib Demonstrated 49% Objective Response Rate in Lung Cancer Patients with High Levels of MET Overexpression and/or Amplification in SAVANNAH Phase&#

— MET is the most common biomarker in patients with EGFR-mutated lung cancer who develop resistance to targeted therapy — — Global SAFFRON Phase III trial evaluating this combination is underway — HONG KONG and SHANGHAI, China and FLORHA...
HCM - HUTCHMED Announces that Fruquintinib Global Phase III FRESCO-2 Study Has Met Its Primary Endpoint in Metastatic Colorectal Cancer

— Trial met primary endpoint of overall survival and all secondary endpoints — — Overall safety consistent with fruquintinib known profile — — Plans for regulatory submissions underway in the U.S., Europe and Japan ȁ...